Chartwell Investment Partners’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-22,000
| Closed | -$423K | – | 440 |
|
|
2019
Q3 | $423K | Sell |
22,000
-48,484
| -69% | -$932K | 0.01% | 392 |
|
|
2019
Q2 | $2.08M | Buy |
70,484
+28,171
| +67% | +$833K | 0.07% | 316 |
|
|
2019
Q1 | $2.01M | Buy |
42,313
+18,578
| +78% | +$883K | 0.07% | 327 |
|
|
2018
Q4 | $857K | Buy |
23,735
+734
| +3% | +$26.5K | 0.03% | 406 |
|
|
2018
Q3 | $1.42M | Buy |
23,001
+32
| +0.1% | +$1.97K | 0.04% | 426 |
|
|
2018
Q2 | $1.55M | Sell |
22,969
-868
| -4% | -$58.7K | 0.05% | 406 |
|
|
2018
Q1 | $1.29M | Sell |
23,837
-321
| -1% | -$17.4K | 0.04% | 352 |
|
|
2017
Q4 | $1.44M | Sell |
24,158
-1,433
| -6% | -$85.6K | 0.05% | 362 |
|
|
2017
Q3 | $1.24M | Buy |
25,591
+791
| +3% | +$38.4K | 0.04% | 372 |
|
|
2017
Q2 | $1.3M | Buy |
24,800
+10
| +0% | +$525 | 0.05% | 332 |
|
|
2017
Q1 | $1.12M | Sell |
24,790
-14,375
| -37% | -$652K | 0.04% | 338 |
|
|
2016
Q4 | $1.48M | Sell |
39,165
-67,550
| -63% | -$2.56M | 0.05% | 345 |
|
|
2016
Q3 | $4.03M | Buy |
+106,715
| New | +$4.03M | 0.07% | 281 |
|
|
2015
Q2 | – | Sell |
-354,045
| Closed | -$11.1M | – | 336 |
|
|
2015
Q1 | $11.1M | Buy |
354,045
+169,140
| +91% | +$5.3M | 0.22% | 176 |
|
|
2014
Q4 | $5.4M | Buy |
+184,905
| New | +$5.4M | 0.11% | 261 |
|